Literature DB >> 2455937

[Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)].

A Schmidtke1, P Fleckenstein, W Moises, H Beckmann.   

Abstract

In both its original and German version, the Montgomery-Asberg Depression-Rating Scale (MADRS) has proved to be efficient and practical, and the level of its interrater reliability would appear to be satisfactorily high. With regard to the detection of changes occurring during the course of a depressive phase, this scale exhibits a degree of sensitivity that is comparable to that reported for the HAMD. The concurrent validity between the MADRS and the HAMD is higher over time (.94) than in cross-section (.85). Factor analyses have demonstrated that the MADRS is capable of recording more psychological symptoms of depression than the HAMD. Thus, the MADRS should be applied in combination with other rating scales. Contrary to the intentions of the devisers of this scale, it has been found that, significantly different assessments may result when the same patient is rated by various groups (psychiatrists, psychologists, students and psychiatric nurses). These differences are of practical relevance and are greatest for the first assessment. Clearly, the selection of the time of rating as well as the length of the time period to be included in the evaluation are of particular importance. Even though it has been emphasized that the operationalization of the MADRS is very good, it would appear that also special training in the use of this rating scale is necessary.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455937

Source DB:  PubMed          Journal:  Schweiz Arch Neurol Psychiatr (1985)        ISSN: 0258-7661


  23 in total

1.  Influence of depressed patients' expectations prior to electroconvulsive therapy on its effectiveness and tolerability (Exp-ECT): a prospective study.

Authors:  Lisa Krech; Michael Belz; Matthias Besse; Isabel Methfessel; Dirk Wedekind; David Zilles
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-09-22       Impact factor: 5.270

2.  Ethnic and migrational impact on the clinical manifestation of depression.

Authors:  Eberhard A Deisenhammer; Müberra Coban-Başaran; Atıl Mantar; Regina Prunnlechner; Georg Kemmler; Tunç Alkın; Hartmann Hinterhuber
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-07-31       Impact factor: 4.328

3.  Elevation of homocysteine levels is only partially reversed after therapy in females with eating disorders.

Authors:  Julia Wilhelm; Elisabeth Müller; Martina de Zwaan; Julia Fischer; Thomas Hillemacher; Johannes Kornhuber; Stefan Bleich; Helge Frieling
Journal:  J Neural Transm (Vienna)       Date:  2010-02-27       Impact factor: 3.575

4.  [Prospective study using a modified Montgomery-Asberg Depression Scale].

Authors:  H-J Möller; J Schnitker
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

5.  Increased involvement of the parahippocampal gyri in a sad mood predicts future depressive symptoms.

Authors:  Vera Zamoscik; Silke Huffziger; Ulrich Ebner-Priemer; Christine Kuehner; Peter Kirsch
Journal:  Soc Cogn Affect Neurosci       Date:  2014-02-03       Impact factor: 3.436

6.  Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa.

Authors:  Stefanie Verena Mueller; Yosuke Morishima; Simon Schwab; Roland Wiest; Andrea Federspiel; Gregor Hasler
Journal:  Neuropsychopharmacology       Date:  2017-11-06       Impact factor: 7.853

7.  A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD).

Authors:  Xinghua Ding; Ruoxu Liu; Wenkai Li; Hengjia Ni; Yong Liu; Dandan Wu; Shuguang Yang; Jing Liu; Bo Xiao; Shaojun Liu
Journal:  Metab Brain Dis       Date:  2015-11-05       Impact factor: 3.584

8.  Trans-Sector Integrated Treatment in Psychosis and Addiction.

Authors:  Euphrosyne Gouzoulis-Mayfrank; Susanne König; Stefan Koebke; Thomas Schnell; Mario Schmitz-Buhl; Jörg Daumann
Journal:  Dtsch Arztebl Int       Date:  2015-10-09       Impact factor: 5.594

9.  Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder.

Authors:  B Frajo-Apor; G Kemmler; S Pardeller; T Plass; M Mühlbacher; A-S Welte; W W Fleischhacker; A Hofer
Journal:  Psychol Med       Date:  2016-09-19       Impact factor: 7.723

10.  Comparison of Subjective and Objective Sleep Estimations in Patients with Bipolar Disorder and Healthy Control Subjects.

Authors:  Philipp S Ritter; Cathrin Sauer; Steffi Pfeiffer; Michael Bauer; Andrea Pfennig
Journal:  Sleep Disord       Date:  2016-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.